Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes Puts Focus on Incoming Chair Warsh Japan Hotel Rates Surge as US and European Tourists Offset Decline in Chinese Visitors SP 500 Notches Modest Gains as Healthcare and Tech Lead Communication Services Lags Mistral AI Considers InHouse Chip Development to Cut Costs and Compete with US Rivals Eli Lillys NextGeneration Obesity Drug Retatrutide Achieves Primary Endpoint in Pivotal Trial Older Workers Least Concerned About AI Job Displacement Fed Data Shows JetBlue Airways JBLU Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Headwinds Emerson Electric Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Higher FIS Q1 2026 Earnings EPS Beats Estimates but Revenue Details Remain Unclear AVNW Q1 2026 Earnings EPS Misses Estimates Sharply Stock Rises Despite Disappointment BXP Q1 2026 Earnings Stellar EPS Beat Signals Strong Operational Execution United Maritime Corporation USEA Q1 2026 Earnings Stellar EPS Beat Lifts Investor Sentiment Home BancShares HOMB Edges Higher as Steady Support Holds SBA Communications SBAC Slips Tower REIT Tests Key Support After 187 Decline SEMR Holds Steady Near Support as Consolidation Continues Core AI Holdings Inc CHAI Slight Pullback as Stock Holds Above Key Support EQV Ventures Acquisition Corp II EVAC Holds Near 10 Level as SPAC Market Watches for Merger Catalysts Marvell Technology Stock Declines Despite AIDriven Revenue Growth Accelerating ALMS Q1 2026 Earnings EPS Beat Partially Offsets Investor Concerns Nabors Industries NBR Slides 379 as Energy Sector Headwinds Intensify Precision Drilling PDS Holds Steady Near 96 Consolidation Within Established Range NMI Holdings Faces Modest Decline Support Levels in Focus for NMIH Consensus Cloud Solutions CCSI Gains 26 as Stock Approaches Key Resistance PS International Group Ltd PSIG Advances 183 Testing Key Resistance at 820 Commercial Metals Company CMC Holds Steady Near Support Amid Sector Strength John Hancock Diversified Income Fund HEQ Holds Steady A Cautious Climb Above Support TransCode Therapeutics RNAZ Gains Over 2 as Biotech Stock Tests Key Resistance Levels